Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11

Trial Status

Completed1
Recruiting1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT07100067Not ApplicableRecruiting
LCAR-F33S in Treatment of Relapsed/Refractory Multiple Myeloma
Relapsed/Refractory Multiple Myeloma(MM)
PrincipalinvestigatorStart date: 2025-09-16
NCT04067414Phase 1Completed
Exploratory Study of CD19-targeted Chimeric Antigen Receptor T Cells(BZ019) for Relapsed and Refractory B-cell Lymphoma
Diffuse Large B Cell LymphomaHigh-grade B-cell LymphomaPrimary Mediastinal Large B Cell Lymphoma+1 more
PrincipalinvestigatorStart date: 2018-06-08

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jae Park, MD

Memorial Sloan Kettering Cancer Center

Related
17 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, DiffusePrimary Mediastinal Large B Cell Lymphoma
Similarity Score12%

Weili Zhao, PhD

Ruijin Hospital

Related
5 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, DiffuseHigh-grade B-cell Lymphoma
Similarity Score12%

Roberto Hernández Martín, MD

Hospital Virgen de la Concha

Related
2 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, Diffuse
Similarity Score6%

Elena Pérez Ceballos, MD

Hospital Morales Meseguer

Related
2 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, Diffuse
Similarity Score6%

Qifa Liu

Nanfang Hospital, Southern Medical University

Related
33 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, Diffuse

Worked with same sponsors:

Institute of Hematology & Blood Diseases Hospital, China
Similarity Score6%

Sarit Assouline, MD

Jewish General Hospital

Related
5 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, Diffuse
Similarity Score6%

Thomas E. Witzig, MD

Mayo Clinic

Related
12 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, Diffuse
Similarity Score6%

Carlos Montalbán Sanz, MD

Hospital Universitario Ramon y Cajal

Related
2 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, Diffuse
Similarity Score6%

Hervé Tilly, MD

Lymphoma Study Association

Related
5 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, Diffuse
Similarity Score6%

Mitchell S Cairo, MD

New York Medical College

Related
13 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, Diffuse
Similarity Score6%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT07100067Not ApplicablePrincipalInvestigator

LCAR-F33S in Treatment of Relapsed/Refractory Multiple Myeloma

Relapsed/Refractory Multiple Myeloma(MM)
Recruiting
NCT04067414Phase 1PrincipalInvestigator

Exploratory Study of CD19-targeted Chimeric Antigen Receptor T Cells(BZ019) for Relapsed and Refractory B-cell Lymphoma

Diffuse Large B Cell LymphomaHigh-grade B-cell LymphomaPrimary Mediastinal Large B Cell Lymphoma+1 more
Completed

All 2 trials loaded